Product Code: TMRGL1169
Continuous Glucose Monitoring Market - Scope of Report
TMR's report on the global Continuous Glucose Monitoring Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global Continuous Glucose Monitoring Market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Continuous Glucose Monitoring Market from 2025 to 2035.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the two-wheeler navigation display market.
Market Snapshot |
Market Value in 2024 | US$ 5.8 Bn |
Market Value in 2035 | US$ 12.6 Bn |
CAGR | 7.4% |
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global two-wheeler navigation display market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global two-wheeler navigation display market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global two-wheeler navigation display market.
The report delves into the competitive landscape of the global two-wheeler navigation display market. Key players operating in the global Continuous Glucose Monitoring Market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Continuous Glucose Monitoring Market profiled in this report.
Key Questions Answered in Global Continuous Glucose Monitoring Market Report:
- What is the sales/revenue generated by apheresis across all regions during the forecast period?
- What are the opportunities in the global two-wheeler navigation display market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2035?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Continuous Glucose Monitoring Market - Research Objectives and Research Approach
The comprehensive report on the global Continuous Glucose Monitoring Market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global Continuous Glucose Monitoring Market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global two-wheeler navigation display market.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Continuous Glucose Monitoring Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Segment Definition
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Continuous Glucose Monitoring Market Analysis and Forecast, 2020 to 2035
- 4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
- 5.1. Disease Prevalence & Incidence Rate globally with key countries
- 5.2. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
- 5.3. Technological Advancements
- 5.4. PORTER's Five Forces Analysis
- 5.5. PESTEL Analysis
- 5.6. Value Chain Analysis
- 5.7. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
- 5.8. Regulatory Scenario by Key Country/Region
- 5.9. Research and Development Trends
- 5.10. Go-to-Market Strategy for New Market Entrants
6. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Type
- 6.1. Introduction & Definition
- 6.2. Key Findings/Developments
- 6.3. Market Value Forecast, by Type, 2020 to 2035
- 6.3.1. Real-Time CGM
- 6.3.2. Intermittently Scanned CGM
- 6.4. Market Attractiveness Analysis, by Type
7. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Component
- 7.1. Introduction & Definition
- 7.2. Key Findings/Developments
- 7.3. Market Value Forecast, by Component, 2020 to 2035
- 7.3.1. Sensor
- 7.3.2. Transmitter
- 7.3.3. Receiver
- 7.4. Market Attractiveness Analysis, by Component
8. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Age Group
- 8.1. Introduction & Definition
- 8.2. Key Findings/Developments
- 8.3. Market Value Forecast, by Age Group, 2020 to 2035
- 8.3.1. Children
- 8.3.2. Adults
- 8.4. Market Attractiveness Analysis, by Age Group
9. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Indication
- 9.1. Introduction & Definition
- 9.2. Key Findings/Developments
- 9.3. Market Value Forecast, by Indication, 2020 to 2035
- 9.3.1. Type 1 Diabetes
- 9.3.2. Type 2 Diabetes
- 9.3.3. Others
- 9.4. Market Attractiveness Analysis, by Indication
10. Global Continuous Glucose Monitoring Market Analysis and Forecast, by End-user
- 10.1. Introduction & Definition
- 10.2. Key Findings/Developments
- 10.3. Market Value Forecast, by End-user, 2020 to 2035
- 10.3.1. Hospitals & Clinics
- 10.3.2. Homecare Settings
- 10.3.3. Others
- 10.4. Market Attractiveness Analysis, by End-user
11. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Region
- 11.1. Key Findings
- 11.2. Market Value Forecast, by Region, 2020 to 2035
- 11.2.1. North America
- 11.2.2. Europe
- 11.2.3. Asia Pacific
- 11.2.4. Latin America
- 11.2.5. Middle East & Africa
- 11.3. Market Attractiveness Analysis, by Region
- 12.1. Introduction
- 12.2. Market Value Forecast, by Type, 2020 to 2035
- 12.2.1. Real-Time CGM
- 12.2.2. Intermittently Scanned CGM
- 12.3. Market Value Forecast, by Component, 2020 to 2035
- 12.3.1. Sensor
- 12.3.2. Transmitter
- 12.3.3. Receiver
- 12.4. Market Value Forecast, by Age Group, 2020 to 2035
- 12.4.1. Children
- 12.4.2. Adults
- 12.5. Market Value Forecast, by Indication, 2020 to 2035
- 12.5.1. Type 1 Diabetes
- 12.5.2. Type 2 Diabetes
- 12.5.3. Others
- 12.6. Market Value Forecast, by End-user, 2020 to 2035
- 12.6.1. Hospitals & Clinics
- 12.6.2. Homecare Settings
- 12.6.3. Others
- 12.7. Market Value Forecast, by Country, 2020 to 2035
- 12.7.1. U.S.
- 12.7.2. Canada
- 12.8. Market Attractiveness Analysis
- 12.8.1. By Type
- 12.8.2. By Component
- 12.8.3. By Age Group
- 12.8.4. By Indication
- 12.8.5. By End-user
- 12.8.6. By Country
13. Europe Continuous Glucose Monitoring Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Type, 2020 to 2035
- 13.2.1. Real-Time CGM
- 13.2.2. Intermittently Scanned CGM
- 13.3. Market Value Forecast, by Component, 2020 to 2035
- 13.3.1. Sensor
- 13.3.2. Transmitter
- 13.3.3. Receiver
- 13.4. Market Value Forecast, by Age Group, 2020 to 2035
- 13.4.1. Children
- 13.4.2. Adults
- 13.5. Market Value Forecast, by Indication, 2020 to 2035
- 13.5.1. Type 1 Diabetes
- 13.5.2. Type 2 Diabetes
- 13.5.3. Others
- 13.6. Market Value Forecast, by End-user, 2020 to 2035
- 13.6.1. Hospitals & Clinics
- 13.6.2. Homecare Settings
- 13.6.3. Others
- 13.7. Market Value Forecast, by Country/Sub-region, 2020 to 2035
- 13.7.1. Germany
- 13.7.2. UK
- 13.7.3. France
- 13.7.4. Italy
- 13.7.5. Spain
- 13.7.6. The Netherlands
- 13.7.7. Switzerland
- 13.7.8. Rest of Europe
- 13.8. Market Attractiveness Analysis
- 13.8.1. By Type
- 13.8.2. By Component
- 13.8.3. By Age Group
- 13.8.4. By Indication
- 13.8.5. By End-user
- 13.8.6. By Country/Sub-region
14. Asia Pacific Continuous Glucose Monitoring Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Type, 2020 to 2035
- 14.2.1. Real-Time CGM
- 14.2.2. Intermittently Scanned CGM
- 14.3. Market Value Forecast, by Component, 2020 to 2035
- 14.3.1. Sensor
- 14.3.2. Transmitter
- 14.3.3. Receiver
- 14.4. Market Value Forecast, by Age Group, 2020 to 2035
- 14.4.1. Children
- 14.4.2. Adults
- 14.5. Market Value Forecast, by Indication, 2020 to 2035
- 14.5.1. Type 1 Diabetes
- 14.5.2. Type 2 Diabetes
- 14.5.3. Others
- 14.6. Market Value Forecast, by End-user, 2020 to 2035
- 14.6.1. Hospitals & Clinics
- 14.6.2. Homecare Settings
- 14.6.3. Others
- 14.7. Market Value Forecast, by Country/Sub-region, 2020 to 2035
- 14.7.1. China
- 14.7.2. Japan
- 14.7.3. India
- 14.7.4. Australia & New Zealand
- 14.7.5. South Korea
- 14.7.6. Rest of Asia Pacific
- 14.8. Market Attractiveness Analysis
- 14.8.1. By Type
- 14.8.2. By Component
- 14.8.3. By Age Group
- 14.8.4. By Indication
- 14.8.5. By End-user
- 14.8.6. By Country/Sub-region
15. Latin America Continuous Glucose Monitoring Market Analysis and Forecast
- 15.1. Introduction
- 15.2. Market Value Forecast, by Type, 2020 to 2035
- 15.2.1. Real-Time CGM
- 15.2.2. Intermittently Scanned CGM
- 15.3. Market Value Forecast, by Component, 2020 to 2035
- 15.3.1. Sensor
- 15.3.2. Transmitter
- 15.3.3. Receiver
- 15.4. Market Value Forecast, by Age Group, 2020 to 2035
- 15.4.1. Children
- 15.4.2. Adults
- 15.5. Market Value Forecast, by Indication, 2020 to 2035
- 15.5.1. Type 1 Diabetes
- 15.5.2. Type 2 Diabetes
- 15.5.3. Others
- 15.6. Market Value Forecast, by End-user, 2020 to 2035
- 15.6.1. Hospitals & Clinics
- 15.6.2. Homecare Settings
- 15.6.3. Others
- 15.7. Market Value Forecast, by Country/Sub-region, 2020 to 2035
- 15.7.1. Brazil
- 15.7.2. Mexico
- 15.7.3. Argentina
- 15.7.4. Rest of Latin America
- 15.8. Market Attractiveness Analysis
- 15.8.1. By Type
- 15.8.2. By Component
- 15.8.3. By Age Group
- 15.8.4. By Indication
- 15.8.5. By End-user
- 15.8.6. By Country/Sub-region
16. Middle East & Africa Continuous Glucose Monitoring Market Analysis and Forecast
- 16.1. Introduction
- 16.2. Market Value Forecast, by Type, 2020 to 2035
- 16.2.1. Real-Time CGM
- 16.2.2. Intermittently Scanned CGM
- 16.3. Market Value Forecast, by Component, 2020 to 2035
- 16.3.1. Sensor
- 16.3.2. Transmitter
- 16.3.3. Receiver
- 16.4. Market Value Forecast, by Age Group, 2020 to 2035
- 16.4.1. Children
- 16.4.2. Adults
- 16.5. Market Value Forecast, by Indication, 2020 to 2035
- 16.5.1. Type 1 Diabetes
- 16.5.2. Type 2 Diabetes
- 16.5.3. Others
- 16.6. Market Value Forecast, by End-user, 2020 to 2035
- 16.6.1. Hospitals & Clinics
- 16.6.2. Homecare Settings
- 16.6.3. Others
- 16.7. Market Value Forecast, by Country/Sub-region, 2020 to 2035
- 16.7.1. GCC Countries
- 16.7.2. South Africa
- 16.7.3. Rest of Middle East & Africa
- 16.8. Market Attractiveness Analysis
- 16.8.1. By Type
- 16.8.2. By Component
- 16.8.3. By Age Group
- 16.8.4. By Indication
- 16.8.5. By End-user
- 16.8.6. By Country/Sub-region
17. Competition Landscape
- 17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
- 17.2. Market Share Analysis, by Company (2024)
- 17.3. Company Profiles
- 17.3.1. Dexcom, Inc.
- 17.3.1.1. Company Overview
- 17.3.1.2. Financial Overview
- 17.3.1.3. Product Portfolio
- 17.3.1.4. Business Strategies
- 17.3.1.5. Recent Developments
- 17.3.2. Abbott
- 17.3.2.1. Company Overview
- 17.3.2.2. Financial Overview
- 17.3.2.3. Product Portfolio
- 17.3.2.4. Business Strategies
- 17.3.2.5. Recent Developments
- 17.3.3. Medtronic
- 17.3.3.1. Company Overview
- 17.3.3.2. Financial Overview
- 17.3.3.3. Product Portfolio
- 17.3.3.4. Business Strategies
- 17.3.3.5. Recent Developments
- 17.3.4. Ypsomed AG
- 17.3.4.1. Company Overview
- 17.3.4.2. Financial Overview
- 17.3.4.3. Product Portfolio
- 17.3.4.4. Business Strategies
- 17.3.4.5. Recent Developments
- 17.3.5. Senseonics Holdings, Inc.
- 17.3.5.1. Company Overview
- 17.3.5.2. Financial Overview
- 17.3.5.3. Product Portfolio
- 17.3.5.4. Business Strategies
- 17.3.5.5. Recent Developments
- 17.3.6. A. Menarini Diagnostics S.r.l.
- 17.3.6.1. Company Overview
- 17.3.6.2. Financial Overview
- 17.3.6.3. Product Portfolio
- 17.3.6.4. Business Strategies
- 17.3.6.5. Recent Developments
- 17.3.7. Signos, Inc.
- 17.3.7.1. Company Overview
- 17.3.7.2. Financial Overview
- 17.3.7.3. Product Portfolio
- 17.3.7.4. Business Strategies
- 17.3.7.5. Recent Developments
- 17.3.8. F. Hoffmann-La Roche Ltd
- 17.3.8.1. Company Overview
- 17.3.8.2. Financial Overview
- 17.3.8.3. Product Portfolio
- 17.3.8.4. Business Strategies
- 17.3.8.5. Recent Developments
- 17.3.9. Nemaura
- 17.3.9.1. Company Overview
- 17.3.9.2. Financial Overview
- 17.3.9.3. Product Portfolio
- 17.3.9.4. Business Strategies
- 17.3.9.5. Recent Developments
- 17.3.10. Bionime Corporation
- 17.3.10.1. Company Overview
- 17.3.10.2. Financial Overview
- 17.3.10.3. Product Portfolio
- 17.3.10.4. Business Strategies
- 17.3.10.5. Recent Developments
- 17.3.11. Intelligo BV.
- 17.3.11.1. Company Overview
- 17.3.11.2. Financial Overview
- 17.3.11.3. Product Portfolio
- 17.3.11.4. Business Strategies
- 17.3.11.5. Recent Developments